Kushenin combined with entecavir for chronic hepatitis B: A protocol for a systematic review and meta-analysis

BACKGROUND: A recent study has reported that there are >240 million patients infected with chronic hepatitis B (CHB) worldwide. Once patients with CHB start antiviral treatment, they need to take antiviral drugs for a long period, which may lead to a series of side effects, and the resistance to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yunxia, Zhang, Jiayuan, Jin, Yuxia, Xiao, Xiao, Zhang, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004585/
https://www.ncbi.nlm.nih.gov/pubmed/32000393
http://dx.doi.org/10.1097/MD.0000000000018898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004585/
https://www.ncbi.nlm.nih.gov/pubmed/32000393
http://dx.doi.org/10.1097/MD.0000000000018898

Ejemplares similares